Top Wall Street analysts like these 3 stocks for their solid growth potential
Source: CNBC

AI-linked names posted strong Q2/FY results and drew bullish analyst reactions: Palantir raised full-year guidance and expects U.S. commercial revenue growth of at least 134%, with the segment growing 149% YoY in Q2 and revenue per customer up 76% to $3.5M. Amazon’s AWS revenue jumped 37% (fastest since 2021) with backlog nearly 2.5x to $496B, prompting JPMorgan to lift its 2026/2027 estimates. Lam Research beat expectations, guided to mid-teens upside for the September quarter, and raised 2027 revenue/EPS by 7%/9% to $33B/$8.88 amid AI-driven demand.
Analysis
The market is still lumping three very different AI monetization models into one bucket. PLTR is the most reflexive: its upside is driven by sustained multiple expansion on top of growth, so it benefits most in a risk-on tape but is also the first to crack if enterprise booking momentum normalizes. AMZN is a higher-quality AI beneficiary because the spend can convert into operating leverage across cloud, ads, and fulfillment rather than relying on a single narrative. LRCX is the cleanest second-order winner: it does not need end-demand euphoria, only continued wafer-fab investment, which tends to persist longer than sentiment suggests and pulls through peers like AMAT and KLAC.
Near term, the key catalyst is not whether AI demand exists, but whether it converts into durable backlog and pricing power over the next 1-3 quarters. PLTR’s risk is that the current premium assumes an unusually long runway; any slip in customer expansion or revenue concentration would compress the multiple fast. AMZN’s risk is subtler: if AI capex keeps rising faster than monetization, investors may punish margins even with strong top-line growth. LRCX is supported by a multi-quarter equipment cycle, but the thesis breaks if memory spending pauses or fab buildouts are delayed.
Contrarian take: the consensus may be overpaying for the application-layer story and underpricing the picks-and-shovels names. The better risk/reward is owning infrastructure and platform exposure where incremental AI dollars are easier to verify in backlog and cash flow. If AI is real, the first beneficiaries are the ones selling compute, tools, and equipment—not necessarily the names with the most dramatic headline growth rates.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.60
Ticker Sentiment
Key Decisions for Investors
- Long LRCX vs. short PLTR, 1-3 month pair trade: prefer the equipment/capex transmission over a high-multiple software name; thesis falsifies if PLTR re-accelerates bookings while LRCX guide stalls.
- Add AMZN on pullbacks for a 6-12 month horizon: AI monetization is more defensible through AWS margin leverage and broader operating income upside than pure-play AI software; cut if AWS growth decelerates materially or operating margin fails to expand.
- Use PLTR only tactically, not as a core long, unless you can confirm customer expansion remains above expectations into the next print; otherwise expect multiple compression on any guide miss.
- Watch SOXX/SMH and pair LRCX with AMAT/KLAC for relative-value exposure if you want broader semiconductor capex rather than single-name risk.
- Set an alert on any delay in new fab starts or capex revisions: that is the fastest falsifier for the LRCX bullish thesis and would shift the trade from long to neutral/short.
More News
- Five things to watch in markets in the week ahead
- Palantir Stock Could Make a Dramatic Move Over the Next Year (Hint: It Implies a Big Move)
- AstraZeneca Secures FDA Nod for New Breast Cancer Therapy Etcamah
- Sterling's Electrical Capacity Gets Tight: Can M&A Bridge the Gap?
- ADI Declines 5.6% in a Month: Time to Buy, Sell or Hold the Stock?
- ‘Mistrust' of Palantir may affect NHS research, says health minister